Company Filing History:
Years Active: 2018-2021
Title: Fangyu Liu: Innovator in Pharmaceutical Dosage Forms
Introduction
Fangyu Liu is a notable inventor based in Saratoga, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms for medications. With a total of 3 patents to his name, Liu's work focuses on improving the delivery and effectiveness of pharmaceutical compounds.
Latest Patents
Liu's latest patents include innovative formulations for fingolimod, a drug used in the treatment of multiple sclerosis. His first patent, titled "Stable Solid Fingolimod Dosage Forms," describes a solid pharmaceutical dosage form that contains fingolimod or its pharmaceutically acceptable salts, conjugates, or complexes. This formulation is designed to rapidly disintegrate in a patient's oral cavity, enhancing the drug's bioavailability. The second patent, "Stable Fingolimod Dosage Forms," reiterates similar advancements in the formulation, emphasizing the rapid disintegration feature that is crucial for patient compliance and effectiveness.
Career Highlights
Throughout his career, Fangyu Liu has worked with various organizations that focus on pharmaceutical development. Notably, he has been associated with Handa Pharmaceuticals LLC and Handa Neuroscience, LLC. His experience in these companies has allowed him to refine his expertise in drug formulation and delivery systems.
Collaborations
Due to space constraints, the details of collaborations will not be included in this article.
Conclusion
Fangyu Liu's contributions to the pharmaceutical industry, particularly through his innovative patents, highlight his commitment to improving medication delivery systems. His work continues to impact the field positively, paving the way for more effective treatments.